Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr;39(2):165-73.
doi: 10.1007/s40596-014-0198-4. Epub 2014 Sep 13.

The cost of inpatient care of schizophrenia in the Polish and Ukrainian academic centers--Poznan and Lviv

Affiliations

The cost of inpatient care of schizophrenia in the Polish and Ukrainian academic centers--Poznan and Lviv

Tomasz Zaprutko et al. Acad Psychiatry. 2015 Apr.

Abstract

Objective: The authors aimed to analyze and compare treatments of schizophrenia in Poznan and Lviv to present the potential differences between Poland and Ukraine in pharmacotherapy and economic availability of medicines, to emphasize the role of academic centers in the effective treatment of schizophrenia, and to raise the awareness of residents about economics and the cost of inpatient care.

Methods: The analysis was based on 307 hospital records of patients treated in 2010 and 2011 and data from the hospital accounting department. Per the inclusion criteria, 108 adult patients (50 in Poznan and 58 in Lviv) were enrolled in the study. Monetary values were converted into euros (EUR) at the rate published by the National Bank of Poland (NBP) on October 9, 2012.

Results: The total cost of schizophrenia treatment in Poznan was EUR 160,489.26, x = EUR 3,209.78 per patient, and in Lviv it was EUR 30,943.38, x = EUR 533.5 per patient. Treatment schedules differed between Poznan and Lviv, and pharmacotherapy was limited economically, especially in Lviv.

Conclusion: Although the results differ between Poznan and Lviv, the study shows that schizophrenia treatment is expensive in both centers. Differences in the health care systems make use of innovative neuroleptics unavailable especially in Lviv, which may contribute to non-compliance or higher level of relapses. Distinctive efforts to improve therapies should be made and efforts to equalize access to innovative pharmacotherapy should be supported to improve the therapy's efficacy and the economic values of schizophrenia treatment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Cost of the inpatient care of schizophrenia in Lviv (Euro). Source: based on results of our own studies
Fig. 2
Fig. 2
Cost of the inpatient care of schizophrenia in Poznan (Euro). Source: based on results of our own studies

References

    1. Araszkiewicz A. (editor): Biała Księga, Osoby chorujące na schizofrenię w Polsce, Raport 2011; 6-35.
    1. Green Paper – Improving the mental health of the population: towards a strategy on mental health for the European Union, Brussels, 14.10.2005.
    1. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Eur Neurospsychopharmacol. 2005;15:357–376. doi: 10.1016/j.euroneuro.2005.04.012. - DOI - PubMed
    1. Estimation by ILO. http://agency.osha.eu.int/publications/newsletter/8/en/index_23.htm (accessed 07.12.2010).
    1. Garcia-Ruiz A, Costillas LP, Montesinos AC, Alcalde J, Oyagüez I, Casado M. Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses. Health Econ Rev. 2012; 2:8. www.healtheconomicsreview.com/content/2/1/8 (accessed 05.07.2013). - PMC - PubMed

Publication types

Substances

LinkOut - more resources